365 related articles for article (PubMed ID: 12348212)
1. New year, new option: Cyclo-Provera awaits word.
Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212
[TBL] [Abstract][Full Text] [Related]
2. FDA board investigates Depo-Provera safety.
Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
[TBL] [Abstract][Full Text] [Related]
3. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
4. FDA advisory panel recommends approval for Depo-Provera.
Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
[TBL] [Abstract][Full Text] [Related]
5. Not FDA-approved, but experts recommend Depo-Provera.
Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
[TBL] [Abstract][Full Text] [Related]
6. Depo-Provera highly effective as injectable contraceptive.
Denniston GC
Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
[TBL] [Abstract][Full Text] [Related]
7. Injectable contraception: the USA perspective.
Kaunitz AM
IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
[TBL] [Abstract][Full Text] [Related]
8. The wait for a monthly combined hormonal injectable may be over soon.
Contracept Technol Update; 1999 Nov; 20(11):125-7. PubMed ID: 12295326
[TBL] [Abstract][Full Text] [Related]
9. Clinicians clash with consumer groups over possible Depo ban.
Contracept Technol Update; 1995 Jan; 16(1):11-4. PubMed ID: 12319319
[TBL] [Abstract][Full Text] [Related]
10. Cyclofem shoots into injectable market.
Family Plan World; 1992; ():19. PubMed ID: 12290896
[TBL] [Abstract][Full Text] [Related]
11. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
Greenspan A
Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
[TBL] [Abstract][Full Text] [Related]
12. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
13. Controversy over Depo-Provera.
Wash Drug Device Lett; 1977 Jan; 9(1):2. PubMed ID: 12335988
[TBL] [Abstract][Full Text] [Related]
14. USAID negotiating Depo purchase, but shelf life proves problematic.
Family Plan World; 1993; 3(4):7, 21. PubMed ID: 12288090
[TBL] [Abstract][Full Text] [Related]
15. Medicolegal issues surrounding Depo-Provera easily overcome.
Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
[TBL] [Abstract][Full Text] [Related]
16. Millions of couples to have choice of injectable contraceptive.
Integration; 1996; (47):41. PubMed ID: 12347310
[TBL] [Abstract][Full Text] [Related]
17. Depo-Provera: costs eat up clinic contraceptive budgets.
Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive research: still inadequate after all these years?
Diconsiglio JM
Family Plan World; 1992; 2(6):14. PubMed ID: 12344623
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
Entre Nous Cph Den; 1996 May; (32):11. PubMed ID: 12222270
[TBL] [Abstract][Full Text] [Related]
20. FDA review panel gives thumbs up to Norplant.
Wash Memo Alan Guttmacher Inst; 1989 May; ():3-5. PubMed ID: 12290752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
